Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Chazouilleres

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Hepatology (Baltimore, Md.)|June 27, 2006
Development of autoimmune hepatitis in patients with typical primary biliary cirrhosisRaoul Poupon, Olivier Chazouilleres, Christophe Corpechot, et al.
Journal of Autoimmunity|February 28, 2004
Immune response to lipopolysaccharide in primary biliary cirrhosis and autoimmune diseasesEric Ballot, Olivia Bandin, Olivier Chazouilleres, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 24, 2009
Significance of antibodies to soluble liver antigen/liver pancreas: a large French studyViolaine Eyraud, Olivier Chazouilleres, Eric Ballot, et al.
Gastroenterologie Clinique Et Biologique|April 28, 2009
Liver and inflammatory bowel diseaseS Nahon, J-F Cadranel, Olivier Chazouilleres, et al.
World Journal of Gastroenterology|June 21, 2008
Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitisHarry Sokol, Jacques Cosnes, Olivier Chazouilleres, et al.
JHEP Reports : Innovation in Hepatology|September 27, 2022
Survey uncovering variations in the management of primary sclerosing cholangitis across EuropeJohanna Eliasson, Bobby Lo, Christoph Schramm, et al.
Digestive Diseases and Sciences|December 16, 2024
Unexplained Chronically Elevated Aminotransferases: Liver Biopsy Gives Major Information with Therapeutic Implication in One Patient Out of SevenOlivia Pietri, Matthieu Chicaud, Tony Andreani, et al.
Clinical Pharmacology and Therapeutics|June 28, 2002
Effect of interferon alpha-ribavirin bitherapy on cytochrome P450 1A2 and 2D6 and N-acetyltransferase-2 activities in patients with chronic active hepatitis CLaurent Becquemont, Olivier Chazouilleres, Lawrence Serfaty, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2019
Rate of Spleen Length Progression Is a Marker of Outcome in Patients With Primary Sclerosing CholangitisFranziska Jung, Nora Cazzagon, Eik Vettorazzi, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational studyLawrence Serfaty, Antoine De Leusse, Olivier Rosmorduc, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Hepatology (Baltimore, Md.)|June 27, 2006
Development of autoimmune hepatitis in patients with typical primary biliary cirrhosisRaoul Poupon, Olivier Chazouilleres, Christophe Corpechot, et al.
Journal of Autoimmunity|February 28, 2004
Immune response to lipopolysaccharide in primary biliary cirrhosis and autoimmune diseasesEric Ballot, Olivia Bandin, Olivier Chazouilleres, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 24, 2009
Significance of antibodies to soluble liver antigen/liver pancreas: a large French studyViolaine Eyraud, Olivier Chazouilleres, Eric Ballot, et al.
Gastroenterologie Clinique Et Biologique|April 28, 2009
Liver and inflammatory bowel diseaseS Nahon, J-F Cadranel, Olivier Chazouilleres, et al.
World Journal of Gastroenterology|June 21, 2008
Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitisHarry Sokol, Jacques Cosnes, Olivier Chazouilleres, et al.
JHEP Reports : Innovation in Hepatology|September 27, 2022
Survey uncovering variations in the management of primary sclerosing cholangitis across EuropeJohanna Eliasson, Bobby Lo, Christoph Schramm, et al.
Digestive Diseases and Sciences|December 16, 2024
Unexplained Chronically Elevated Aminotransferases: Liver Biopsy Gives Major Information with Therapeutic Implication in One Patient Out of SevenOlivia Pietri, Matthieu Chicaud, Tony Andreani, et al.
Clinical Pharmacology and Therapeutics|June 28, 2002
Effect of interferon alpha-ribavirin bitherapy on cytochrome P450 1A2 and 2D6 and N-acetyltransferase-2 activities in patients with chronic active hepatitis CLaurent Becquemont, Olivier Chazouilleres, Lawrence Serfaty, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2019
Rate of Spleen Length Progression Is a Marker of Outcome in Patients With Primary Sclerosing CholangitisFranziska Jung, Nora Cazzagon, Eik Vettorazzi, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational studyLawrence Serfaty, Antoine De Leusse, Olivier Rosmorduc, et al.
Pageof 3